about
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesThe role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancerUp-front and Salvage Transoral Robotic Surgery for Head and Neck Cancer: A Belgian Multicenter Retrospective Case SeriesPostoperative photodynamic therapy as a new adjuvant treatment after robot-assisted salvage surgery of recurrent squamous cell carcinoma of the base of tongueEvaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases.In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma.Prognostic Significance of Glutathione Peroxidase Levels (GPx1) in Head and Neck Cancers.Role and value of diffusion-weighted MRI in the radiotherapeutic management of head and neck cancer.Hypoxia as a target for combined modality treatments.Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis.Salvage Transoral Laser Microsurgery for Radiorecurrent Laryngeal Cancer: Indications, Limits, and Outcomes.Radiation-induced xerostomia in patients with head and neck cancer: a literature review.The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review.Salivary gland carcinomas: molecular abnormalities as potential therapeutic targets.Radiosensitizing potential of epigenetic anticancer drugs.Nuclear p16INK4a expression predicts enhanced radiation response in head and neck cancers.Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy.Dysphagia in head and neck cancer patients treated with chemoradiotherapy.Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.A case series of embryonal rhabdomyosarcoma of the head and neck in adults.Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.Tongue cancers during pregnancy: Case reports and review of literature.Radiotherapy for head and neck cancer: an increasing dependence on innovative imaging.Elevated carcinoembryonic antigen tumour marker caused by head and neck cancer: a case report and literature study.Advances in Radiotherapy for Head and Neck Cancer.Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours.HPV-positive head and neck tumours, a distinct clinical entity.Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity.The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer.p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors.FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinoma.Towards 3D printed multifunctional immobilization for proton therapy: Initial materials characterization.Redefining the target early during treatment. Can we visualize regional differences within the target volume using sequential diffusion weighted MRI?Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters.Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART).Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: evaluation in a rat rhabdomyosarcoma model.A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.Differences in human papillomavirus-positive and -negative head and neck cancers in Belgium: an 8-year retrospective, comparative study.
P50
Q26752584-67592183-D226-4B46-94C9-5850D30C59F8Q26765957-40AFC123-C711-478D-AA33-E422C6E61DFBQ30399047-4D281367-953E-4969-A167-570BB7262644Q30657818-2E29C221-7BA6-4C25-905A-05FFF1F48A2FQ31038204-388E72FC-B3D5-489C-AEAC-07038FA4736DQ31925991-C78732E7-5F5B-428B-968E-E3AF63344A36Q33633077-AE8483AE-29E3-4F8F-804F-2625F7991B13Q33652692-373FED67-7BC8-4F80-98DE-74F0C15B0508Q33690816-5C456B3B-5392-4DF9-BA47-9BF0D131377EQ34501934-45537120-AFD4-42B0-AC24-68AE2EC27FCFQ35030236-79179F61-9294-47E4-A521-B57FD80A8FF5Q36331359-DACD4344-9D06-492F-A630-98A0AC93C274Q36641026-0FFF43DC-EB46-4AC7-AA50-8F1A5D1FD0ABQ36808687-D8C163E4-9054-47F5-AD4F-4C1D42186356Q37129542-917872C4-095C-4D03-B054-C9E91108FEF8Q37370154-1D28F17D-1D03-45D6-A5DA-074C7B44EECDQ37437660-CC709D38-DF3C-4D98-85FB-6F572AAA8702Q37585493-69EA0E89-A515-4522-96FD-4D42782EA230Q37587805-73355077-ED11-4FFD-B5D8-1BD576980837Q37719626-67F2CD88-CB8C-46D7-B9A1-56DA4593A862Q37832489-2BD67AE7-C761-4339-87D7-17264189BF00Q37874587-057976F9-B2F2-4083-B17A-7950C57308B5Q37947198-B252D0E5-6E9E-431E-A1AA-6B63285ACE25Q38032436-D1F22AF3-34FF-44D4-89A5-FEF04D4D02C3Q38279978-16672D26-D682-4A28-8C7B-42491734C29DQ38412635-17025F74-A08B-4C22-90EB-9EB141C9C41DQ38450187-43269531-5769-4021-8B6C-222B3E1C1EC6Q38603044-3DED0759-9751-4405-8765-A1741FDBBD0EQ38631945-9D4B4920-7125-4B22-9B1F-7B05C94614CBQ38653660-9A33AA9E-7617-4F89-B277-86F7C9202C6FQ38939280-013612ED-D87F-44EB-83BD-EBC85B364EA8Q39029551-07D37AA1-0524-48C5-8DB3-B3C29273CADBQ39095142-5DFE2244-85E5-45C2-B021-857BE501A7A7Q39248674-670030DA-A753-47D0-8ACC-E82652F6324AQ39315212-34024E46-3BEA-42C5-9842-1966B3BDD9E0Q39492726-2BAF3AA8-BBA7-43A0-94D7-F28D9EA586E5Q39746367-E846590B-FD3A-42BB-8A7A-377861FE58ABQ39841529-09A8692B-EF58-440A-9430-E913EEB3DD01Q39884081-56790A54-0945-417C-978A-8CDF524AFE32Q40077854-9718C006-DE7F-4653-AFB8-99B1118C3804
P50
description
researcher
@en
wetenschapper
@nl
name
S Nuyts
@en
S Nuyts
@nl
type
label
S Nuyts
@en
S Nuyts
@nl
prefLabel
S Nuyts
@en
S Nuyts
@nl
P106
P31
P496
0000-0002-5540-4796